Joaquin Fernández-Irigoyen

32PUBLICATIONS
132CO-AUTHORS
Toxicology (incl. clinical toxicology)Neurology and neuromuscular diseasesGenomicsMolecular targetsComposite and hybrid materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 30, 2026
Olfactory proteomics reveals the capacity of the HDAC1 inhibitor pyroxamide to halt the α-synuclein preformed fibrils-induced damage in nasal epithelial, microglial and dopaminergic neuronal cell lines.

|Mar 04, 2026
Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.

Sergio Roca-Pereira, Yaiza López-Sampere, Pol Mengod-Soler

|Dec 31, 2025
4R-tau seeding activity reveals molecular subtypes in progressive supranuclear palsy.

Ivan Martinez-Valbuena, Seojin Lee, Enrique Santamaria

|Oct 18, 2024
Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis.

Carlos G Ardanaz, Aida de la Cruz, Paras S Minhas

|Jul 19, 2024
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.

Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio

|Jun 27, 2024
Drug-Induced Reorganisation of Lipid Metabolism Limits the Therapeutic Efficacy of Ponatinib in Glioma Stem Cells.

Paula Aldaz, Ana Olias-Arjona, Irene Lasheras-Otero

Pageof 6

Frequent Collaborators

27 joint publications

Enrique Santamaría

6 joint publications

Paz Cartas-Cejudo

5 joint publications

Karina Ausin

4 joint publications

Isidro Ferrer